This rarity made Adagen an orphan product—a drug or device that treats a rare disease. Back in 1983, as part of the Orphan Drug Act, the US defined rare diseases as those affecting fewer than ...

The Adagen market is experiencing steady growth ... oStrong regulatory support for orphan drugs. oGreater government focus on rare diseases. oExpansion of specialty drug programs.